Macroaxis: Personalized Investing
Simple Personalized Investing

S&P 500   1,667   17.00  Index Moved Up 1.03%
CVS CVS WAG GNC Consumer Synthetics Data Storage Exotic 
United States  USA  |  Investing Themes


Processing
Processing. Please wait...

PharMerica insider: Frank Collins

       

Frank Collins - PharMerica Insider Profile

Independent Director

Mr. Frank E. Collins is an Independent Director of Pharmerica Corporationration, since July 31, 2007. Mr. Collins was the Senior Vice President, Legal and Administration and Secretary of Sierra Health Services, Inc. from 2001 to February 2008. Sierra was acquired by United Health Group Incorporated in February 2008. Mr. Collins now serves as the Deputy General Counsel of United. Mr. Collins joined Sierra in 1986 as General Counsel and Secretary. From 1981 to 1986, Mr. Collins was employed by Blue Cross and Blue Shield of Kansas City, originally as Staff Legal Counsel and in early 1986 as Associate General Counsel. Mr. Collins served as counsel for the Missouri Division of Insurance from 1979 to 1981, where he was responsible for providing legal advice on insurance and HMOrelated regulatory issues
Age: 57  Director Since 2007      
Frank Collins EducationCollins received his Juris Doctor from the University of Missouri at Kansas City School of Law and is a member of the Missouri Bar Association.

Management Efficency

The company has Return on Asset of 5.32 % which means that on every $100 spent on asset it made $5.32 of profit. This is considered to be average in the sector. In the same way, it shows return on shareholders equity (ROE) of 5.35 % implying that it generated $5.35 on every 100 dollars invested.
The company has 315.5 M in debt with debt to equity (D/E) ratio of 0.71 which is OK given its current industry classification. PharMerica Corporation has Current Ratio of 3.96 demonstrating that it is liquid and is capable to disburse its financial commitments when the payables are due.
    

Other Executives

Entity Summary

PharMerica Corporationration operates as an institutional pharmacy services company in the United States. PharMerica Corporation [PMC] is traded on New York Stock Exchange in USA. It is located in Louisville, KY and employs 5,000 people. Filter other
    
Specify Title
Indicate Tenure
Select Industry
Click to run this filter
 Run Equity Filter
Filter Other Insiders
 
    
    
PMC United States NYSE
PharMerica Corporation
Currency: USD - US Dollar
Traded on New York Stock Exchange
    
    
Chance of
Bankruptcy
Less
Than
33%
In The Next
Two Years
PharMerica Corporation has less than 33.11 (%) percent chance of experiencing financial distress in the next 2 years of operations.
    
    

PharMerica price boundaries

    
April 22 2013
 12.81 
  
 12.33 
(0.48)  Macroaxis: -3.747072599531619 Down   3.75%  
Lowest period price (30 days)
May 10 2013
 14.36 
  
 14.35 
(0.0100)  Macroaxis: -0.06963788300835506 Down   0.07%  
Highest period price (30 days)
    

Promote PharMerica and Frank Collins

Follow PharMerica with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker
Add To Reader
 
Add PharMerica to your reader
 

Today Change

 United States Russel   1.11 % Macroaxis: change 1.11 Moved Up  
 
 United States SP 500   1.03 % Macroaxis: change 1.03 Moved Up  
 
 United States NYSE   0.92 % Macroaxis: 0.92 Moved Up  
 
 United States Nasdaq   0.69 % Macroaxis: 0.69 Moved Up  
 
 thisGreen PMC PMC agains markets  0.21 % Macroaxis: 0.21 Moved Up  
 

Stock Performance

Shares Outstanding29.54 M
Number of Shares Shorted2.82 M


 
Analytics
Risk Adjusted Returns Landscape
Live Efficient Frontier
Market Correlation Analysis
Watchlist Analysis
Financial Content
Portfolio Estimation and Projections
Portfolio Theme Builder
 
 
Research Modules
Equities Backtesting Analysis
Instant Retirement Optimizer
Cross-portfolio RSS and Mobile Access
Company, fund, and ETF Directory
Financial Advisor Directory
Insider and Manager Directory
Wealth Management
 Gadgets, Widgets, and Apps          
  
 
Services And Technology
Frequently Asked Questions
Quick Product Tour
Product Technology Overview
Solution Methodology
Plans and Pricing
 
Free Investor Tools
World Market Correlations
Instant Equity Comparator
Watchlist Analysis
Position Suggestions
Equity Alpha Analysis
 
About Us
About Macroaxis
Contact Us
Product Terms Of Use
Service Privacy Policy
Advertising Opportunities
Content

Thanks for checking out Macroaxis

Tell us what you like and what you don't like. We promise we'll not only listen but write you back

Contact Us
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide. Please fill out our quick survey to help us provide your with a better service and user experience

Fill Out Quick Survey
Most of the functionality on our site is free to use. However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory

Go Premium